Topiramate attenuates cerebral ischemia/reperfusion injury in gerbils via activating GABAergic signaling and inhibiting astrogliosis

• DOI: 10.1016/j.neuint.2011.10.015
• Publication Date: 2011-11-08T19:50:04Z
• Authors: Xiaoyuan Mao; Changwei Ji; Chunyan Sun; Danfeng Cao; Ping Ma; Zhong Ji; Fangyuan Cao; Dongyu Min; Shuzhi Li; Jiqun Cai; Yonggang Cao
• Keywords: Male; Neurons; 0301 basic medicine; Cell Death; Apoptosis; Fructose; Receptors, GABA-A; Hippocampus; Brain Ischemia; 03 medical and health sciences; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Topiramate; Astrocytes; Reperfusion Injury; Glial Fibrillary Acidic Protein; Animals; Gliosis; Apoptosis Regulatory Proteins; Gerbillinae; bcl-2-Associated X Protein

Impaired GABAergic inhibitory synaptic transmission plays an essential role in the pathogenesis of selective neuronal cell death following transient global ischemia. GABA(A) receptor (GABA(A)R), K⁺-Cl⁻ co-transporter 2 (KCC2), Na⁺-K⁺-Cl⁻ co-transporter 1 (NKCC1) and astrocytes are of particular importance to GABAergic transmission. The present study was designed to explore whether the neuroprotective effect of topiramate (TPM) was linked with the alterations of GABAergic signaling and astrocytes. The bilateral carotid arteries were occluded, and TPM (80 mg/kg/day (divided twice daily), i.p.) was injected into gerbils. At day 1, 3 and 7 post-ischemia, neurological deficit was scored and changes in hippocampal neuronal cell death were evaluated by Nissl staining. The apoptosis-related regulatory proteins (procaspase-3, caspase-3, Bax and Bcl-2) and GABAergic signal molecules (GABA(A)R α1, GABA(A)R γ2, KCC2 and NKCC1) were also detected using western blot assay. In addition, the fluorescent intensity and protein level of glial fibrillary acidic protein (GFAP), a major component of astrocyte, were examined by confocal and immunoblot analysis. Our results showed that TPM treatment significantly decreased neurological deficit scores, attenuated the ischemia-induced neuronal loss and remarkably decreased the expression levels of procaspase-3, caspase-3 as well as the ratio of Bax/Bcl-2. Besides, treatment with TPM also resulted in the increased protein expressions of GABA(A)R α1, GABA(A)R γ2 and KCC2 together with the decreased protein level of NKCC1 in gerbils hippocampus. Furthermore, fluorescent intensity and protein level of GFAP were evidently reduced in TPM-treated gerbils. These findings suggest that the therapeutic effect of TPM on global ischemia/reperfusion injury appears to be associated with the enhancement of GABAergic signaling and the inhibition of astrogliosis in gerbils.